| David Adamczyk, PT | |
|
1100 Shawnee Rd, Lima, OH 45805-3529 | |
| (419) 999-2010 | |
| (419) 999-6284 |
| Full Name | David Adamczyk |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 27 Years |
| Location | 1100 Shawnee Rd, Lima, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346909710 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT010349 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Encompass Care, Inc. | 2062752595 | 19 |
News Archive
Switzerland's innovative policy of providing drug addicts with free methadone and clean needles has greatly reduced deaths while cutting crime rates and should serve as a global model, health experts said on Monday, Reuters reports in an article that examines the outcomes of drug policy reform in the country
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
In a special issue of Immunotherapy, leading experts provide in-depth review of innovative strategies that may further the success of adoptive cell immunotherapy as a cancer treatment. Adoptive cell immunotherapy (ACT) has proven successful in clinical trials against certain types of melanoma and leukemia. The journal reviews new strategies to address the challenges of extending these effects to a wider range of tumor types.
Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, announced the presentation today of updated preliminary results from its ongoing Phase 1 clinical study of DCC-2618, the company's broad-spectrum KIT and PDGFRα inhibitor, in patients with gastrointestinal stromal tumors as a proffered paper presentation at the European Society of Medical Oncology 2018 Congress in Munich, Germany.
A team led by the University of South Florida Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered) received a $1.45-million funding award for a three-year project from the Patient-Centered Outcomes Research Institute to continue to advance and expand the ABOUT Network as part of the second phase of PCORnet: the National Patient-Centered Clinical Research Network.
› Verified 7 days ago
| Provider Name | Encompass Care, Inc. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1770107088 PECOS PAC ID: 2062752595 Enrollment ID: O20200724002029 |
News Archive
Switzerland's innovative policy of providing drug addicts with free methadone and clean needles has greatly reduced deaths while cutting crime rates and should serve as a global model, health experts said on Monday, Reuters reports in an article that examines the outcomes of drug policy reform in the country
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
In a special issue of Immunotherapy, leading experts provide in-depth review of innovative strategies that may further the success of adoptive cell immunotherapy as a cancer treatment. Adoptive cell immunotherapy (ACT) has proven successful in clinical trials against certain types of melanoma and leukemia. The journal reviews new strategies to address the challenges of extending these effects to a wider range of tumor types.
Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, announced the presentation today of updated preliminary results from its ongoing Phase 1 clinical study of DCC-2618, the company's broad-spectrum KIT and PDGFRα inhibitor, in patients with gastrointestinal stromal tumors as a proffered paper presentation at the European Society of Medical Oncology 2018 Congress in Munich, Germany.
A team led by the University of South Florida Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered) received a $1.45-million funding award for a three-year project from the Patient-Centered Outcomes Research Institute to continue to advance and expand the ABOUT Network as part of the second phase of PCORnet: the National Patient-Centered Clinical Research Network.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Adamczyk, PT 1100 Shawnee Rd, Lima, OH 45805-3529 Ph: (419) 999-2010 | David Adamczyk, PT 1100 Shawnee Rd, Lima, OH 45805-3529 Ph: (419) 999-2010 |
News Archive
Switzerland's innovative policy of providing drug addicts with free methadone and clean needles has greatly reduced deaths while cutting crime rates and should serve as a global model, health experts said on Monday, Reuters reports in an article that examines the outcomes of drug policy reform in the country
A paper published by Elsevier and authored by Professor Nidal Hilal and his team at Swansea University has become the most cited article in the international journal Desalination since 2012 according to SciVerse ScienceDirect, a leading full-text scientific database
In a special issue of Immunotherapy, leading experts provide in-depth review of innovative strategies that may further the success of adoptive cell immunotherapy as a cancer treatment. Adoptive cell immunotherapy (ACT) has proven successful in clinical trials against certain types of melanoma and leukemia. The journal reviews new strategies to address the challenges of extending these effects to a wider range of tumor types.
Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, announced the presentation today of updated preliminary results from its ongoing Phase 1 clinical study of DCC-2618, the company's broad-spectrum KIT and PDGFRα inhibitor, in patients with gastrointestinal stromal tumors as a proffered paper presentation at the European Society of Medical Oncology 2018 Congress in Munich, Germany.
A team led by the University of South Florida Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered) received a $1.45-million funding award for a three-year project from the Patient-Centered Outcomes Research Institute to continue to advance and expand the ABOUT Network as part of the second phase of PCORnet: the National Patient-Centered Clinical Research Network.
› Verified 7 days ago
Dr. Kyle T Shroll, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 801 Medical Dr Ste A, Lima, OH 45804 Phone: 419-222-6622 Fax: 419-224-0015 | |
Kristin Doll, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2535 Fort Amanda Rd, Lima, OH 45804 Phone: 419-999-2055 | |
Susan Sheehan, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1920 Slabtown Rd, Lima, OH 45801 Phone: 419-222-1836 | |
Tyler Green, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1100 Shawnee Rd, Lima, OH 45805 Phone: 419-999-2010 Fax: 419-999-6284 | |
Back On Track Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 3477 S Dixie Hwy, Lima, OH 45804 Phone: 567-356-4385 Fax: 419-738-8002 | |
Mrs. Amy Little, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 804 S Mumaugh Rd, Lima, OH 45804 Phone: 419-225-9040 Fax: 419-225-9292 | |
Timothy Walsh, P.T., M.A. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4825 Sugar Creek Rd, Lima, OH 45807 Phone: 419-996-9650 Fax: 888-881-8547 |